Research Topic: anticancer agents

Algal pigments: Therapeutic potential and food applications

mycolabadmin

Colorful algae contain powerful natural compounds that can help treat serious health problems like cancer, diabetes, and obesity. Scientists are using special nano-technology to deliver these algal compounds more effectively in medicines. Algae-based pigments like chlorophyll and carotenoids are already used in supplements and healthy foods to boost overall wellness. These compounds also help maintain a healthy gut and reduce inflammation in the body.

Read More »

Biosynthesis of bimetallic silver–copper oxide nanoparticles using endophytic Clonostachys rosea ZMS36 and their biomedical applications

mycolabadmin

Scientists discovered a special fungus living inside a medicinal plant that can create tiny silver-copper nanoparticles with powerful antibacterial and anti-cancer properties. These nanoparticles successfully fought dangerous bacteria like MRSA and slowed the growth of cancer cells while being safe to healthy cells. This green manufacturing method is much more environmentally friendly than traditional chemical approaches and could lead to new treatments for infections and cancer.

Read More »

Investigation of the antifungal activity of panobinostat, tamoxifen, and miltefosine alone and in combination with some conventional antifungal drugs against fluconazole-resistant Candida species

mycolabadmin

Researchers tested whether three cancer drugs (panobinostat, tamoxifen, and miltefosine) could enhance the effectiveness of common antifungal medications against drug-resistant yeast infections. When combined with antifungals, some of these cancer drugs showed promise in killing resistant Candida species, though the effectiveness varied depending on which type of yeast was being treated. These findings suggest that combination therapies using already-approved drugs could help treat difficult fungal infections in cancer patients.

Read More »

Anticancer Activity of Demethylincisterol A3 and Related Incisterol-Type Fungal Products

mycolabadmin

This review examines a group of rare fungal compounds called incisterols, with a focus on demethylincisterol A3 (DM-A3), which has shown promise as an anticancer agent. DM-A3 works through multiple mechanisms including blocking cancer cell signaling pathways, inhibiting specific enzymes, and reducing inflammation. The compound has demonstrated effectiveness against various cancer types in laboratory studies and showed tumor-reducing effects in animal models, suggesting potential for future cancer therapy development.

Read More »

Ergostane-type steroids from mushrooms of Pleurotus genus

mycolabadmin

Oyster mushrooms and king trumpet mushrooms contain special compounds called ergostane-type steroids that have interesting chemical structures. These compounds can fight inflammation and may help with cancer. Scientists have discovered that some of these compounds have unique rearranged structures that don’t exist in other organisms. These mushroom-derived compounds show promise for developing new medicines.

Read More »

Advances in Fungal Natural Products: Insights into Bioactivity and Therapeutic Potential

mycolabadmin

Medicinal mushrooms and fungi contain powerful natural chemicals that can boost immunity, reduce inflammation, fight cancer, and protect the brain. Scientists are now better able to identify and study these compounds using advanced techniques, and some are being tested as supplements or alongside traditional medicines. This research shows that mushrooms could become important tools in treating diseases like inflammatory bowel disease, rheumatoid arthritis, and cancer.

Read More »

Acetophenone-Based 3,4-Dihydropyrimidine-2(1H)-Thione as Potential Inhibitor of Tyrosinase and Ribonucleotide Reductase: Facile Synthesis, Crystal Structure, In-Vitro and In-Silico Investigations

mycolabadmin

Scientists created a new chemical compound that shows promise in fighting skin cancer, particularly melanoma. The compound is seven times more effective at blocking tyrosinase, an enzyme involved in skin pigmentation and cancer growth, compared to existing drugs. Computer simulations and laboratory tests confirmed that this compound can also interfere with DNA replication processes that cancer cells depend on, suggesting it could be developed into a new cancer treatment with fewer side effects.

Read More »
Scroll to Top